Who is the only entity authorized to monitor prescribing practices using a DEA number?

The Drug Enforcement Administration (DEA) is the entity authorized to monitor prescribing practices using a DEA number. This authority stems from the DEA's responsibility for enforcing the controlled substances laws and regulations of the United States. They track the prescribing and dispensing of controlled substances to ensure compliance with federal laws, prevent drug misuse, and manage drug enforcement strategy effectively.

The DEA issues unique identifiers (DEA numbers) to practitioners, allowing them to prescribe controlled substances legally. By monitoring these numbers, the DEA can identify and investigate potential misuse or illegal prescribing practices, thus playing a central role in ensuring public safety and maintaining the integrity of the healthcare system regarding controlled substances.

Other entities, like the State Pharmacy Board, Department of Health, and Federal Trade Commission, do not have the same level of authority or specific mandate to monitor DEA numbers directly related to prescribing practices for controlled substances. Each of these organizations has its own jurisdiction and responsibilities but does not encompass the comprehensive enforcement and regulatory framework that the DEA provides in this area.